Improving patient reporting of medication issues during cancer care transitions
Patient Engagement in Reporting Medication Events during Transitions of Care
This study is all about making sure cancer patients and their families can easily share their experiences and concerns about medication safety, especially for those taking cancer pills at home, so that everyone can work together to improve care and keep patients safe during their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10872120 on NIH RePORTER |
What this research studies
This research focuses on enhancing the safety of cancer patients during transitions of care by engaging them and their families in reporting medication-related events. It aims to develop a user-friendly platform that allows patients to share their experiences and concerns about medication safety, particularly for those taking oral anticancer agents at home. By leveraging technology, the project seeks to identify barriers to patient engagement and improve the reporting process, ultimately leading to better patient outcomes. The study will explore how informed patients can provide valuable feedback to healthcare providers, fostering safer care transitions.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are currently undergoing treatment with oral anticancer agents and their families.
Not a fit: Patients who are not undergoing treatment for cancer or those who are not taking oral anticancer medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved safety and outcomes for cancer patients during critical transitions in their care.
How similar studies have performed: Previous research has shown that engaging patients in reporting safety events can be effective, but this specific approach to cancer care transitions is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Jiang, Yun — University of Michigan at Ann Arbor
- Study coordinator: Jiang, Yun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.